CUL4A and neoplasm: Matching tendencies in gene alteration were evidenced in GATA4A (AFX: 5/10, 50% and PDS: 1/13, 8%, p = 0.0501) (Figure 7a), MPL (AFX: 3/10, 30% and PDS: 0/13, p = 0.0593), CUL4A (AFX: 3/10, 30% and PDS: 0/13, p = 0.0593) alterations in AFX tumor samples and CDH1 (AFX: 0/10, PDS: 5/13, 38% p = 0.053) (Figure 7b) alterations in PDS tumors.